Lois Mulligan PhD

Dr. Mulligan completed her PhD in Medical Genetics at Queen’s University and went on to further training focusing on molecular genetics of rare cancer syndromes. Her research on the molecular mechanisms of inherited thyroid cancers led to the discovery of the role of the RET oncogene in endocrine tumours and its contributions to a number of cancers. Dr. Mulligan is a Professor of Pathology and Molecular Medicine, and a member of the Division of Cancer Biology and Genetics, Cancer Research Institute at Queens University. Her primary research interests are in understanding the molecular, cellular and clinical roles of the RET receptor tyrosine kinase in normal and cancer cells.